Novartis updates Scemblix label; registers PV real-world study and CAD trialSep 24Weekly roundup, 3 itemsasciminibNovartis
Enliven reports Phase 1 CML data for ELVN-001, aligns with FDA on Phase 3 designAug 5Quarterly updateEnliven Therapeutics
Novartis: Mayzent label update approved; four real-world studies registered or recruitingJul 2Weekly roundup, 7 itemsalpelisibFludarabine
Sign inSign in